An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Neeta Tandon, MA
Advertisement
Articles by Neeta Tandon, MA
Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Advertisement
Latest Updated Articles
- Rheumatoid Arthritis and Joint Replacement: Impact of Biologics
December 16th 2014
- Direct and Indirect Cost Burden of Chronic Hepatitis C
September 25th 2015
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5